Skip to main content
. 2018 Apr 10;109(5):1570–1575. doi: 10.1111/cas.13556

Figure 1.

Figure 1

Kaplan‐Meier for time to prostate‐specific antigen (PSA) progression (A) and overall survival (B) in total population (n = 41)